prostate treatment

[Guest guest]

A treatment mainstay for prostate cancer puts men at increased risk for diabetes and cardiovascular disease, according to a large observational study published in the Sept. 20 Journal of Clinical Oncology. "Men with prostate cancer have high five-year survival rates, but they also have higher rates of non-cancer mortality than healthy men," says study author Nancy Keating, MD, MPH, assistant professor of health care policy and of medicine at Harvard Medical School. "This study shows that a common hormonal treatment for prostate cancer may put men at significant risk for other serious diseases. Patients and physicians need to be aware of the elevated risk as they make treatment decisions."

 

Reply with your name and street or po box address for your freecopy of The Holistic Dental Digest PLUS, now in its 27th year and helping people on 5 continents. jmittelman --What dentists aren't likely to learn in Dental School

 

[Guest guest]

The news that chemical castration is no good is no surpise; it's not

even news, except to onclogists, that they got the treatment

backwards.

 

As Dr. John Lee pointed out for years, prostate treatment with

progesterone and testosterone,the exact opposite of chemical

castration, reverses BPH and slows or stops prostate cancer growth.

 

The study abstract, " Diabetes and cardiovascular disease during

androgen deprivation therapy for prostate cancer. "

(J Clin Oncol. 2006 Sep) http://tinyurl.com/l5o3q

 

Duncan Crow.

 

, " Jerry Mittelman "

<jmittelman wrote:

>

> A treatment mainstay for prostate cancer puts men at increased risk

for diabetes and cardiovascular disease, according to a large

observational study published in the Sept. 20 Journal of Clinical

Oncology.

>

> " Men with prostate cancer have high five-year survival rates, but

they also have higher rates of non-cancer mortality than healthy

men, " says study author Nancy Keating, MD, MPH, assistant professor

of health care policy and of medicine at Harvard Medical

School. " This study shows that a common hormonal treatment for

prostate cancer may put men at significant risk for other serious

diseases. Patients and physicians need to be aware of the elevated

risk as they make treatment decisions. "

>

>

>

>

>